Century Therapeutics FY EPS $(2.30) Misses $(2.09) Estimate, Sales $2.23M Miss $3.82M Estimate
Portfolio Pulse from Benzinga Newsdesk
Century Therapeutics reported a FY EPS of $(2.30), missing the $(2.09) estimate, and sales of $2.23M, missing the $3.82M estimate. This represents a decrease in performance compared to the same period last year.
March 14, 2024 | 11:36 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Century Therapeutics reported a larger than expected quarterly loss and a significant miss in sales estimates.
Missing both EPS and sales estimates significantly, especially with a year-over-year decrease in performance, typically leads to negative investor sentiment and could result in a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100